Bennett Lawrence Management’s Gilead Sciences GILD Stock Holding History

Bennett Lawrence Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-27,095	Closed	-$2.55M	–	91
2014 Q4	$2.55M	Sell	27,095 -3,610	-12%	-$373K	0.69%	54
2014 Q3	$3.27M	Buy	30,705 +15,705	+105%	+$1.54M	0.74%	53
2014 Q2	$1.24M	Sell	15,000 -93,275	-86%	-$7.26M	0.22%	71
2014 Q1	$7.67M	Sell	108,275 -22,105	-17%	-$1.73M	1.14%	34
2013 Q4	$9.79M	Sell	130,380 -15,680	-11%	-$1.09M	1.5%	29
2013 Q3	$9.18M	Sell	146,060 -3,975	-3%	-$238K	1.49%	29
2013 Q2	$7.69M	Buy	+150,035	New	+$7.82M	1.47%	28

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Bennett Lawrence Management's GILD Position: Q1 2015 in Review

Bennett Lawrence Management sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 27,095 shares — an estimated $2.55M sold.

Bennett Lawrence Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $9.79M in Q4 2013. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

Bennett Lawrence Management reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
Bennett Lawrence Management sold 27,095 Gilead Sciences shares in Q1 2015, an estimated $2.55M.
Bennett Lawrence Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
Bennett Lawrence Management's Gilead Sciences position peaked at $9.79M in Q4 2013.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Bennett Lawrence Management's 13F filing for Q1 2015, filed 20 Apr 2015.